Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of CXA-10 in Healthy Obese Men
NCT02460146Phase 1Completed
- Sponsor
- Complexa Therapeutics
- Start
- Apr 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in acute kidney injury (AKI) comparing CXA-10 with Placebo (2 arms). Primary endpoint: Safety (adverse events) and tolerability at 14 days. Started Apr 2015; status: completed.
02
Drugs
10-nitro-oleic acid
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02460146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460146.